Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Yang

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 19, 2012
Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanomaBradley J Seaman, Elizabeth A Guardiani, Carmen C Brewer, et al.
Immunity|January 3, 2012
αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificitiesAnastasia N Tikhonova, François Van Laethem, Ken-ichi Hanada, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2021
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung AdenocarcinomaYue A Qi, Tapan K Maity, Constance M Cultraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 19, 2012
Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanomaBradley J Seaman, Elizabeth A Guardiani, Carmen C Brewer, et al.
Immunity|January 3, 2012
αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificitiesAnastasia N Tikhonova, François Van Laethem, Ken-ichi Hanada, et al.
Molecular & Cellular Proteomics : MCP|August 15, 2021
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung AdenocarcinomaYue A Qi, Tapan K Maity, Constance M Cultraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Pageof 16